Galeon's Groundbreaking Funding for Drug Repurposing in Medical Research
Repurposing Drugs for Maximum DeSci Impact
Repurposing existing drugs for new diseases holds immense promise for faster and more affordable treatments. However, traditional funding models often fall short due to centralized control and misaligned priorities. Galeon's DeSci approach disrupts this paradigm.
Galeon Pioneers: A Community of Scientific Innovators
Galeon's vision is to decentralize access to secure medical data across hospitals, fostering a global community of passionate researchers and innovators – the Galeon Pioneers. This empowers a collaborative environment where scientific innovation thrives.
Community-Driven Funding: DAO for Promising Research
Galeon is seeking promising drug repurposing candidates. Up to €500,000 will be allocated to fund essential studies, with projects selected by an independent scientific committee. Uniquely, Galeon's DAO, co-governed by patients (50%) and $GALEON token holders (50%), will also participate in the selection process. This DAO ensures funding is directed towards research with the greatest potential to benefit patients.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.